Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230) (Q79995276)
Jump to navigation
Jump to search
scientific article published on 01 August 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230) |
scientific article published on 01 August 2006 |
Statements
Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230) (English)
Glen Clack
Jack Cuzick
Mitch Dowsett
Judith E Adams
ATAC Trialists' group
1 August 2006